Trial intelligence / Profile preview

Pharmacokinetics of Ciprofloxacin and Imipenem in Healthy Subjects and Pneumonia Patients

NCT03177720Phase 1Completed

Sponsor
Medical University of Vienna
Start
May 2016
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial in pneumonia comparing Ciprofloxacin with Imipenem (2 arms). Primary endpoints: Peak Concentration at 10 hours, Area Under the Concentration Curve at 10 hours and 7 more. Started May 2016; status: completed.

02

Drugs

ciprofloxacinimipenem
03

Conditions

pneumonia

Beyond the preview

Go deeper on NCT03177720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03177720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call